Whether you’re in the clinic with your patients or collecting data remotely, we can find a secure and compliant solution that meets your needs. Most importantly, when we add new features to our platform, we rely on your expertise and guidance to make sure our tools work the way you need them to.
Yes, we have a fully integrated platform of products—proven products and services that are flexible and can be scaled to meet your unique needs. And, it’s our expert understanding of a broad spectrum of industries that makes us the right choice. Whether you’re a CRO, pharmaceutical, biotech, medical device, diagnostics, or animal health company, we make it easier for you to collect high-quality, clean, verified data while maintaining full control of your study and your data.
Being known for efficient clinical trials increases your chances of partnering with pharmaceutical and diagnostic companies, as well as device manufacturers. Medrio’s enhanced training and excellent customer support (as little or as much as you require), are just some of the ways we can establish you as a go-to CRO. We also understand the critical need for oversight and monitoring by your executive staff, which is why our integrated platform of real-time data makes it easy for leadership to run whatever reports they need.
Our teams have run thousands of studies and we can confidently support your unique therapeutic needs. A Medrio expert is standing by to review your protocol and provide guidance on the best solutions for you.
Our top therapeutic areas include:
When you partner with us, we’ll help you meet changing regulatory requirements and even train your new study staff. If you have a challenge, we will work tirelessly to find a solution, just like we did with one of our recent clients who had to go live with their study less than two weeks after implementing new software. Although they had in-person training scheduled in Perth, Australia, our customer service team helped them begin training staff immediately using virtual technology.
Sign up to have our the latest insights delivered to your inbox.